Martin Trbusek

Brno, JM 62500, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes.

Journal: BMC cancer

Published: May 20, 2021

Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion.

Rituximab induces rapid blood repopulation by CLL cells mediated through their release from immune niches and complement exhaustion.

Journal: Leukemia research

Published: February 06, 2021

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: February 21, 2020

PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.

PRIMA-1MET cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells.

Journal: Leukemia research

Published: October 01, 2019

Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.

Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti

Published: August 15, 2019

ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.

ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias.

Journal: Cancer treatment reviews

Published: July 17, 2019

Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.

Impact of gene mutations and chromosomal aberrations on progression-free survival in chronic lymphocytic leukemia patients treated with front-line chemoimmunotherapy: Clinical practice experience.

Journal: Leukemia research

Published: February 28, 2019

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.

Journal: Leukemia & lymphoma

Published: January 11, 2019

Detection and Functional Analysis of TP53 Mutations in CLL.

Detection and Functional Analysis of TP53 Mutations in CLL.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: October 24, 2018

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.

Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cells.

Journal: Haematologica

Published: July 31, 2018

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.

miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.

Journal: Blood

Published: June 10, 2018

Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.

Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia.

Journal: Annals of hematology

Published: May 20, 2018

Showing 1-12 of 41

Last Updated: 09/26/2026